Navigation

Investiment.io
Financial analysis platform

Merck & Co., Inc.

MRK โ€ข NYSE

$144.46
โ–ผ3.30 (2.23%)โ€ข REGULAR

Merck & Co., Inc.

$144.46
โ–ผ2.2%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading
โš–๏ธ

Balance SheetMRK

Balance Sheet Summary

Key balance sheet metrics and financial position for MRK

๐Ÿข
Total Assets
$136,866,000
(in thousands USD)
๐Ÿ“‹
Total Liabilities
N/A
(in thousands USD)
๐Ÿ‘ฅ
Shareholders' Equity
$52,606,000
(in thousands USD)
โš–๏ธ
Debt-to-Equity Ratio
0.89
Long-term Debt / Equity

Balance Sheet Analysis

Analyze assets, liabilities, and equity trends over time

Period:annual

Select Metrics to Compare (4 selected)

Total Assets Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$35.00B$70.00B$105.00B$140.00B-6%0%+6%+12%+18%
  • Total Assets
  • Total Assets YoY Growth

Total Liabilities Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$1.00K$2.00K$3.00K$4.00K
  • Total Liabilities
  • Total Liabilities YoY Growth

Total Shareholders' Equity Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$15.00B$30.00B$45.00B$60.00B-30%-15%0%+15%+30%
  • Total Shareholders' Equity
  • Total Shareholders' Equity YoY Growth

Cash and Cash Equivalents Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 20250.004000000000.008000000000.0012000000000.0016000000000.00-50%0%+50%+100%+150%
  • Cash and Cash Equivalents
  • Cash and Cash Equivalents YoY Growth